Description

Rosulist – A 10/75 Capsules (Aspirin Gastro Resistant + Rosuvastatin 10 mg + 75 mg)

The pharma industry in India is growing rapidly. A growing population plus an increase in lifestyle ailments like heart problems, hypertension, cholesterol, and Cardiac Risks has boosted the demand of Cardiac and Lipid Management Drugs. Cardiac and Lipid Management Medicines like combinations of Aspirin Gastro Resistant with Rosuvastatin (pills) are preferred by Doctors in Hospitals and Chemists for Better Cardio vascular Protection.

This sector has a good scope of Pharmaceutical products, and Biophar Lifesciences has various Pharma Products like Rosulist A 10/75 Capsules with a strong Pharma Franchise network to support and third-party manufacturing. Biophar Lifesciences is one of the most trusted pharma companies in India, providing the best quality medicines, PCD pharma franchise, and Third Party manufacturing. The company is committed to providing good health and a better life to people with safe, effective, and affordable medicines and supporting other pharma distributors and healthcare entrepreneurs to grow their own pharmaceutical business.

Benefits of Biophar Lifesciences PCD Pharma Franchise

Monopoly Rights

In addition, Biophar Lifesciences offers sole rights to the distributors, meaning they can work on their own within the region assigned to them without having to compete for customers.

High-Quality Pharmaceutical Products

The promise of providing safe, effective, and reliable medicines that meet healthcare standards.

Strong Product Portfolio

Biophar Lifesciences offers medicines across multiple segments, like:

• Management of Cardiology and Diabetic Conditions
• Gastroenterology
• Antibiotics
• Pain management
• Nutraceuticals
• Injectables

This wide frame of healthcare access enables our franchise partners to be able to avail themselves of a wide array of healthcare services.

Marketing Support

The business offers promotional materials including display pieces, product cards, MR bag, prescription pad, and other promotional items.

Timely Supply Chain

Ensuring the availability of products that are always accessible throughout India is the role of well-managed logistics systems.

Advantages of Third Party Manufacturing

Cost-Effective Business Model

Avoid costly investments in machinery, infrastructure, and production facilities.

Advanced Manufacturing Facilities

The practice has invested in cutting-edge technology as well as pharmaceutical-grade manufacturing processes.

Wide Product Range

Biophar Lifesciences offers Tablets, Capsules, Syrups, Injections, and Speciality medicines.

Customized Packaging

Offers packaging and branding to other companies.

Quality Assurance

All products are rigorously tested for quality to ensure both safety and efficacy.

Importance of Cardiac Medicines in Healthcare

Cardiovascular Diseases are one of the major health problems in India due to stress, unhealthy diet, lifestyle changes, and a decline in the number of physical activities. So the demand for cardiac medicines is consistently on the increase.

Rosulist A 10/75 Capsules are useful in the treatment of hypercholesterolaemia and in preventing cardiovascular events.

Used in the management of Lipid concentrations, healthcare professionals opt for the combination therapies with a higher benefit and preventive aspects. Biophar Lifesciences is strengthening its cardiac portfolio to address the increasing healthcare needs of the country.

Why Choose Biophar Lifesciences?

Biophar Lifesciences is an established pharmaceutical company due to the quality of its products, customer focus, and business growth support.

Key Advantages

• High-quality cardiac and specialty medicines
• Monopoly pharma franchise opportunities
• Strong third-party manufacturing services
• Wide pharmaceutical product portfolio
• Attractive profit margins
• Timely product delivery
• Professional marketing support
• Ethical business practices
• Consistent quality assurance

The firm is always trying to develop the quality of a product and try to increase the portfolio of pharmaceuticals.